Anti-Human KLRC1 Recombinant Antibody (Monalizumab) (CAT#: TAB-437CQ)
Recombinant monoclonal antibody to KLRC1. Monalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Head and neck cancer.
Specific Inquiry
WB
Figure 1 Anti-Human KLRC1 Recombinant Antibody (TAB-437CQ) in WB
Western blot analysis of KLRC1 Antibody was performed with Recombinant Human KLRC1 protein.
Lane 1: Reducing antigen (0.6 μg)
The secondary antibody: HRP Goat Anti-Human IgG (H+L)
The purity of NS-027CN was greater than 95% as determined by SDS-PAGE.
ELISA
Figure 2 Anti-Human KLRC1 Recombinant Antibody (TAB-437CQ) in ELISA
ELISA analysis of TAB-437CQ was performed by coating with Recombinant Human KLRC1 Protein. Then blocked with BSA, and incubated with Anti-Human KLRC1 Therapeutic Antibody (Monalizumab) (TAB-437CQ). The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
DB
Figure 3 Anti-Human KLRC1 Recombinant Antibody (TAB-437CQ) in DB
Antigen: Human KLRC1 protein Antibody incubation concentration: 2 ng/μL.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized
- Type
- IgG4, κ
- Specificity
- Human KLRC1
- Species Reactivity
- Human
- Applications
- Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
- Conjugate
- Unconjugated
- CAS
- 1228763-95-8
- Generic Name
- Monalizumab
- UNII
- 3ZXZ2V0588
- Related Disease
- Head and neck cancer
Product Property
- Purity
- > 95% as determined by SDS-PAGE
- Storage
- Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Target
Related Resources
Please refer to Monalizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Monalizumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Monalizumab"
Afuco™ Anti-KLRC1 ADCC Recombinant Antibody (Monalizumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to KLRC1. Monalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Head and neck cancer.
See other products for "KLRC1"
Recombinant Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-604 | Recombinant Anti-human KLRC1 Antibody | WB, Neut, FuncS | IgG |
| MHH-604 | Recombinant Human Anti-human KLRC1 Antibody | ELISA, WB, FC, FuncS | IgG |
| MOB-0225CT | Recombinant Mouse anti-Human KLRC1 Monoclonal antibody (NN0598-9T47) | WB | |
| MOR-1968 | Hi-Affi™ Recombinant Rabbit Anti-KLRC1 Monoclonal Antibody (DS1968AB) | IHC-P, WB | IgG |
Fab Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-604-F(E) | Recombinant Anti-human KLRC1 Antibody Fab Fragment | RIA, ELISA, FuncS | Fab |
| MHH-604-F(E) | Recombinant Human Anti-human KLRC1 Antibody Fab Fragment | Neut, IF, FuncS | Fab |
scFv Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-604-S(P) | Recombinant Anti-human KLRC1 Antibody scFv Fragment | ELISA, IF, FuncS | scFv |
| MHH-604-S(P) | Recombinant Human Anti-human KLRC1 Antibody scFv Fragment | WB, Neut, FuncS | scFv |
Humanized Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0338CL | Human Anti-KLRC1 Recombinant Antibody (TAB-0338CL) | IHC | Humanized antibody |
| TAB-0338CL-S(P) | Human Anti-KLRC1 Recombinant Antibody; scFv Fragment (TAB-0338CL-S(P)) | ELISA | Humanized scFv |
| TAB-0338CL-F(E) | Human Anti-KLRC1 Recombinant Antibody; Fab Fragment (TAB-0338CL-F(E)) | ELISA | Humanized Fab |
ADCC Enhanced Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-437CQ | Afuco™ Anti-KLRC1 ADCC Recombinant Antibody (Monalizumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-437CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.